Biostar Pharmaceuticals Inc (BSPM) Stock Balloons on Easy Breathing Launch

Biostar Pharmaceuticals Inc (BSPM) is fresh off an annual high

Oct 11, 2016 at 3:01 PM
facebook twitter linkedin

Biostar Pharmaceuticals Inc (NASDAQ:BSPM) more than doubled in value earlier en route to an annual high of $7.06. At last check, the biotech stock was still up 92.4% at $6.60, making it the top percentage gainer on the Nasdaq -- unlike shares of this rental concern.

Sending BSPM gapping higher is the launch of the company's Easy Breathing rhinitis and sinusitis treatment in China. Biostar said it expects to sell 400,000 units of the health product within the next two years, which should yield around $7.5 million in revenue.

Suffice it to say, one group of traders dodged a huge bullet on the stock -- specifically, short sellers. Short interest plunged 65.2% during the last two reporting periods, leaving just 2.4% of BSPM's float sold short.

While Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is breaking out today, a long-term chart reveals that the shares have quite a way to go to return to their glory days. For instance, back in April 2010, the biotech stock was sitting in triple-digit territory.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners